Study of Pomalidomide in Anal Cancer Precursors

Clinical trial NCT03113942 · UNKNOWN

Trial details

NCT number: NCT03113942
Sponsor: Kirby Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

High Grade Squamous Intra-epithelial Lesion (HSIL)

Start date: 2017-06-14
Primary completion: 2019-03-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.